Regenics’ idea is to locally revive the regenerative abilities of skin cells in order to improve wound healing by the use of extracts from salmon eggs. 

Regenics is developing medical device wound healing products, for CE-marking under class IIa, IIb or III, dependant on final claims. The technology is  based on extensive purification of cytoplasmic fraction of salmon roe and patented in US, EU and RoW.

 

 

Scientifically documented and patented claims in wound healing:

  • VERNEX™ increases reepitelialization in human skin explants with second degree burns
  • VERNEX™ is skin safety tested
  • VERNEX™ increases fibroblast migration
  • VERNEX™ increases collagen synthesis 
  • VERNEX™ enhances hyaluronic acid secretion
  • VERNEX™ increases elastin production
  • VERNEX™ delivered as hydrogel formulation

Regenics AS has developed a number of assays and techniques to study effects of various substances on skin cells both in vitroin vivo and in the clinic. Our focus is to develop products and techniques for therapeutic skin applications and to improve skin appearance.